Your browser doesn't support javascript.
loading
RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis.
Dopeso, Higinio; Rodrigues, Paulo; Cartón-García, Fernando; Macaya, Irati; Bilic, Josipa; Anguita, Estefanía; Jing, Li; Brotons, Bruno; Vivancos, Núria; Beà, Laia; Sánchez-Martín, Manuel; Landolfi, Stefania; Hernandez-Losa, Javier; Ramon Y Cajal, Santiago; Nieto, Rocío; Vicario, María; Farre, Ricard; Schwartz, Simo; van Ijzendoorn, Sven C D; Kobayashi, Kazuto; Martinez-Barriocanal, Águeda; Arango, Diego.
Afiliación
  • Dopeso H; Group of Biomedical Research in Digestive Tract Tumors, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Rodrigues P; Group of Biomedical Research in Digestive Tract Tumors, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Cartón-García F; Group of Biomedical Research in Digestive Tract Tumors, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Macaya I; Group of Biomedical Research in Digestive Tract Tumors, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Bilic J; Group of Biomedical Research in Digestive Tract Tumors, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Anguita E; Group of Biomedical Research in Digestive Tract Tumors, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Jing L; Group of Molecular Oncology, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain.
  • Brotons B; Group of Biomedical Research in Digestive Tract Tumors, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Vivancos N; Group of Molecular Oncology, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain.
  • Beà L; Group of Molecular Oncology, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain.
  • Sánchez-Martín M; Group of Molecular Oncology, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain.
  • Landolfi S; Group of Molecular Oncology, Biomedical Research Institute of Lleida (IRBLleida), 25198 Lleida, Spain.
  • Hernandez-Losa J; Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007 Salamanca, Spain.
  • Ramon Y Cajal S; Servicio de Transgénesis, Nucleus, Universidad de Salamanca, 37007 Salamanca, Spain.
  • Nieto R; Departamento de Medicina, Universidad de Salamanca, 37007 Salamanca, Spain.
  • Vicario M; Translational Molecular Pathology, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Farre R; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
  • Schwartz S; Translational Molecular Pathology, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • van Ijzendoorn SCD; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
  • Kobayashi K; Translational Molecular Pathology, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Martinez-Barriocanal Á; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
  • Arango D; Group of Biomedical Research in Digestive Tract Tumors, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
iScience ; 27(4): 109400, 2024 Apr 19.
Article en En | MEDLINE | ID: mdl-38523777
ABSTRACT
Rho GTPases are molecular switches regulating multiple cellular processes. To investigate the role of RhoA in normal intestinal physiology, we used a conditional mouse model overexpressing a dominant negative RhoA mutant (RhoAT19N) in the intestinal epithelium. Although RhoA inhibition did not cause an overt phenotype, increased levels of nuclear ß-catenin were observed in the small intestinal epithelium of RhoAT19N mice, and the overexpression of multiple Wnt target genes revealed a chronic activation of Wnt signaling. Elevated Wnt signaling in RhoAT19N mice and intestinal organoids did not affect the proliferation of intestinal epithelial cells but significantly interfered with their differentiation. Importantly, 17-month-old RhoAT19N mice showed a significant increase in the number of spontaneous intestinal tumors. Altogether, our results indicate that RhoA regulates the differentiation of intestinal epithelial cells and inhibits tumor initiation, likely through the control of Wnt signaling, a key regulator of proliferation and differentiation in the intestine.
Palabras clave